title: Better use of immune checkpoint inhibition: Treating higher risk patients and examining neurologic toxicity.
authors.affiliation: Melanoma and Immunotherapeutics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.|Department of Medicine, Weill Cornell Medical College, New York, USA.
authors.forename: M A
authors.initials: MA
authors.lastname: Postow
mesh_terms: D006801:Humans; D007167:Immunotherapy; D061026:Programmed Cell Death 1 Receptor / Q000276:immunology*
chemical_list: D061026:Programmed Cell Death 1 Receptor